These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

913 related items for PubMed ID: 10091735

  • 1. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.
    Boyages J, Delaney G, Taylor R.
    Cancer; 1999 Feb 01; 85(3):616-28. PubMed ID: 10091735
    [Abstract] [Full Text] [Related]

  • 2. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M.
    Breast Cancer Res Treat; 2008 Jun 01; 109(3):405-16. PubMed ID: 17687650
    [Abstract] [Full Text] [Related]

  • 3. Ductal carcinoma in situ. The success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies.
    Lagios MD, Silverstein MJ.
    Surg Oncol Clin N Am; 1997 Apr 01; 6(2):385-92. PubMed ID: 9115503
    [Abstract] [Full Text] [Related]

  • 4. Local recurrences after conservative treatment of ductal carcinoma-in-situ of the breast without radiotherapy: the effect of age.
    Schouten van der Velden AP, Peeters PH, Koot VC, Hennipman A.
    Ann Surg Oncol; 2006 Jul 01; 13(7):990-8. PubMed ID: 16788762
    [Abstract] [Full Text] [Related]

  • 5. Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience.
    Padmore RF, Fowble B, Hoffman J, Rosser C, Hanlon A, Patchefsky AS.
    Cancer; 2000 Mar 15; 88(6):1403-9. PubMed ID: 10717623
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C, Kestin L, Go N, Krauss D, Chen P, Goldstein N, Martinez A, Vicini FA.
    Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1514-21. PubMed ID: 16005576
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Predictors of local recurrence following excision alone for ductal carcinoma in situ.
    Hetelekidis S, Collins L, Silver B, Manola J, Gelman R, Cooper A, Lester S, Lyons JA, Harris JR, Schnitt SJ.
    Cancer; 1999 Jan 15; 85(2):427-31. PubMed ID: 10023711
    [Abstract] [Full Text] [Related]

  • 11. Predictors of surgical margin status in breast-conserving surgery within a breast screening program.
    Kurniawan ED, Wong MH, Windle I, Rose A, Mou A, Buchanan M, Collins JP, Miller JA, Gruen RL, Mann GB.
    Ann Surg Oncol; 2008 Sep 15; 15(9):2542-9. PubMed ID: 18618180
    [Abstract] [Full Text] [Related]

  • 12. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ.
    Dunne C, Burke JP, Morrow M, Kell MR.
    J Clin Oncol; 2009 Apr 01; 27(10):1615-20. PubMed ID: 19255332
    [Abstract] [Full Text] [Related]

  • 13. Influence of local treatment on the recurrence rate of ductal carcinoma in situ.
    Warneke J, Grossklaus D, Davis J, Stea B, Bebb G, Taylor C, Hastings R, Villar H.
    J Am Coll Surg; 1995 Jun 01; 180(6):683-8. PubMed ID: 7773481
    [Abstract] [Full Text] [Related]

  • 14. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
    Sahoo S, Recant WM, Jaskowiak N, Tong L, Heimann R.
    Breast J; 2005 Jun 01; 11(4):242-7. PubMed ID: 15982389
    [Abstract] [Full Text] [Related]

  • 15. An attempt to independently verify the utility of the Van Nuys Prognostic Index for ductal carcinoma in situ.
    MacAusland SG, Hepel JT, Chong FK, Galper SL, Gass JS, Ruthazer R, Wazer DE.
    Cancer; 2007 Dec 15; 110(12):2648-53. PubMed ID: 17960606
    [Abstract] [Full Text] [Related]

  • 16. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
    Fodor J.
    Magy Onkol; 2007 Dec 15; 51(2):127-31. PubMed ID: 17660868
    [Abstract] [Full Text] [Related]

  • 17. Outcomes and factors impacting local recurrence of ductal carcinoma in situ.
    Weng EY, Juillard GJ, Parker RG, Chang HR, Gornbein JA.
    Cancer; 2000 Apr 01; 88(7):1643-9. PubMed ID: 10738223
    [Abstract] [Full Text] [Related]

  • 18. Do sentinel node micrometastases predict recurrence risk in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion?
    Murphy CD, Jones JL, Javid SH, Michaelson JS, Nolan ME, Lipsitz SR, Specht MC, Lesnikoski BA, Hughes KS, Gadd MA, Smith BL.
    Am J Surg; 2008 Oct 01; 196(4):566-8. PubMed ID: 18760400
    [Abstract] [Full Text] [Related]

  • 19. Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery.
    Boland GP, Chan KC, Knox WF, Roberts SA, Bundred NJ.
    Br J Surg; 2003 Apr 01; 90(4):426-32. PubMed ID: 12673743
    [Abstract] [Full Text] [Related]

  • 20. Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast.
    Meijnen P, Oldenburg HS, Peterse JL, Bartelink H, Rutgers EJ.
    Ann Surg Oncol; 2008 Jan 01; 15(1):235-43. PubMed ID: 17987342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.